WinstonWınston
Back
Redcare Pharmacy N.V. logo

Redcare Pharmacy N.V.

RDC.DE
25
Medical - Distribution · Healthcare
Price
€61.90
-1.55 (-2.44%)
Market Cap
€1.25B
Exchange
Frankfurt Stock Exchange
Winston Score
25
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Mixed
Valuation
Data not available

Share count rising — dilution

+12.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 17.9M (2021) → 20.1M (2025)

Winston Score History

The full picture

Redcare Pharmacy is an online pharmacy based in the Netherlands that sells prescription and over-the-counter medicines, health products, and beauty items directly to customers across Europe. It operates websites and apps where people order medications and get them delivered to their homes, cutting out the need to visit a physical pharmacy. The company owns the Shop Apotheke brand and is one of the largest online pharmacies in Europe.

Redcare makes money by selling products directly to consumers, earning a margin on each order. It operates primarily in Germany, which is its biggest market, along with several other European countries including Austria, Switzerland, France, and Italy. The company has scale advantages and brand recognition in a fragmented market, but it is not yet consistently profitable, as heavy investment in growth keeps margins thin. The key growth driver is Germany's rollout of the electronic prescription system, which could significantly increase the volume of prescription drugs sold through online channels.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+20.3% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-50.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

27.7%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~3 years

€128M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

€128M cash & investments at current burn rate

Growth context

Redcare Pharmacy N.V. is growing revenue at 20% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
22.1%
Thin — 22.1% gross margin
Profit after running costs
Operating Margin
1.4%
Thin — 1.4% operating margin
Return on the money invested
ROCE
-1.3%
Weak — -1.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+20.2%
Fast-growing sales (+20.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-3.0%
Burning cash (-3.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.78
Moderate — manageable debt (0.78)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial